Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...

Recursion (Nasdaq: RXRX) said on Wednesday that it had named Vicki Goodman as chief medical officer, effective April 6, 2026, succeeding David Mauro. Goodman had more than two decades of experience in ...

Ms. Angwin, a contributing Opinion writer, is an investigative journalist. See more of our coverage in your search results.Encuentra más de nuestra cobertura en los resultados de búsqueda. Add The New ...